Inventor · disambiguated record
Nicholas E. Bencivenga
Also filed as: BENCIVENGA NICHOLAS E
6 granted patents·3 pending applications·15 citations·filing 2015–2023
77Inventor score
Top patents by PatentIndex Score
9 records- 0192US10227342B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2015·Granted Mar 12, 2019·7 cites·14 claims
- 0291US9796712B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2017·Granted Oct 24, 2017·6 cites·15 claims
- 0377US11001580B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted May 11, 2021·1 cites·14 claims
- 0477US2024208960A1Aminothiazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 0576US11117883B2Benzimidazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted Sep 14, 2021·1 cites·7 claims
- 0675US11958850B2Heteroaryl compounds for kinase inhibitionTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Apr 16, 2024·0 cites·22 claims
- 0771US11753404B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2021·Granted Sep 12, 2023·0 cites·4 claims
- 0865US2019218212A1Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 0964US2022064144A1Benzimidazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas E. Bencivenga files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →